Phase II study of tarceva as third-line treatment in advanced non-small cell lung cancer

被引：0
|
作者：
de Castro, Javier
Pallares, Cinta
Gurpide, Alfonso
Cobo, Manuel
Paz-Ares, Luis
Gonzalez-Larriba, Jose Luis
Insa, Amelia
Domine, Manuel
Sanchez, Rocio
Massuti, Bartomeu
机构：
[1] Hosp La Paz, E-28040 Madrid, Spain
[2] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[3] Clin Univ Navarra, E-03080 Pamplona, Spain
[4] Hosp Carlos Haya, Malaga, Spain
[5] Hosp Univ Doce Octobre, Madrid, Spain
[6] Hosp Clin San Carlos, Madrid, Spain
[7] Hosp Clin, Valencia, Spain
[8] Fdn Jimenez Diaz, Madrid, Spain
[9] Roche Farma Espana, Oncol Unit, Madrid, Spain
[10] Gen Hosp Univ Alicante, Alicante, Spain
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：236 / 236
页数：1
相关论文
共 50 条
  • [11] Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial
    David Rossi
    Donatella Dennetta
    Marcello Ugolini
    Vincenzo Catalano
    Paolo Alessandroni
    Paolo Giordani
    Anna Maria Baldelli
    Virginia Casadei
    Francesco Graziano
    S. Luzi Fedeli
    [J]. Targeted Oncology, 2010, 5 : 231 - 235
  • [12] Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial
    Rossi, David
    Dennetta, Donatella
    Ugolini, Marcello
    Catalano, Vincenzo
    Alessandroni, Paolo
    Giordani, Paolo
    Baldelli, Anna Maria
    Casadei, Virginia
    Graziano, Francesco
    Fedeli, S. Luzi
    [J]. TARGETED ONCOLOGY, 2010, 5 (04) : 231 - 235
  • [13] Erlotinib (Tarceva) for advanced non-small cell lung cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2005, 47 (1205): : 25 - 26
  • [14] PHASE II STUDY OF AMRUBICIN FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER AS THIRD-LINE OR FOURTH-LINE CHEMOTHERAPY: UPDATED RESULTS
    Oizumi, Satoshi
    Harada, Toshiyuki
    Ito, Kenichiro
    Takamura, Kei
    Kuda, Tomoya
    Sugawara, Shunichi
    Watanabe, Kana
    Maemondo, Makoto
    Fujita, Yuka
    Kinoshita, Ichiro
    Inoue, Akira
    Hommura, Fumihiro
    Katsuura, Yutaka
    Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    [J]. RESPIROLOGY, 2013, 18 : 8 - 8
  • [15] Treatment results including more than third-line chemotherapy for patients with advanced non-small cell lung cancer
    Park, Seh Jung
    Choi, In Keun
    Seo, Hee Yun
    Sung, Hwa Jung
    Park, Kyong Hwa
    Oh, Sang Cheul
    Seo, Jae Hong
    Shin, Sang Won
    Kim, Yeul Hong
    Kim, Jun Suk
    [J]. ONCOLOGY LETTERS, 2010, 1 (01) : 51 - 55
  • [16] The Need for Third-line Treatment in Non-small Cell Lung Cancer: An Overview of New Options
    Syrigos, Kostas N.
    Saif, Muhammad W.
    Karapanagiotou, Eleni M.
    Oikonomopoulos, George
    De Marinis, Filippo
    [J]. ANTICANCER RESEARCH, 2011, 31 (02) : 649 - 659
  • [17] Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: Efficacy and tolerability
    Camps, C
    Caballero, C
    Blasco, A
    Safont, MJ
    Berrocal, A
    Garde, J
    Juarez, A
    Sirera, R
    Bremnes, RM
    [J]. ANTICANCER RESEARCH, 2005, 25 (6C) : 4611 - 4614
  • [18] Third-line therapy and beyond for patients with advanced/metastatic non-small cell lung cancer (NSCLC).
    Corral Jaime, Jesus
    Gonzalez de la Pena, Miriam
    Alonso, Miriam
    Sanchez Gastaldo, Amparo
    Dolores Mediano, Maria
    Amerigo, Marta
    Enrique Robles, Carlos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [19] Third-line chemotherapy in advanced non-small cell lung cancer: identifying the candidates in routine practice
    Girard, Nicolas
    Jacoulet, Pascale
    Gainet, Marie
    Elleuch, Rami
    Pernet, Didier
    Depierre, Alain
    Dalphin, Jean-Charles
    Westeel, Virginie
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S680 - S680
  • [20] Third-Line Chemotherapy in Advanced Non-small Cell Lung Cancer: Identifying the Candidates for Routine Practice
    Girard, Nicolas
    Jacoulet, Pascale
    Gainet, Marie
    Elleuch, Rami
    Pernet, Didier
    Depierre, Alain
    Dalphin, Jean-Charles
    Westeel, Virginie
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) : 1544 - 1549
12345